Medical devices in India: a perspective of guidelines and the way forward
Journal: International Journal of Basic & Clinical Pharmacology (Vol.3, No. 5)Publication Date: 2014-10-01
Authors : Sandeep Sewlikar; Nilesh Mahajan; Reshmi Pillai; Anish Desai;
Page : 764-767
Keywords : Medical device; Device classification; Clinical trial; Device safety; Risk;
Abstract
In recent times, emerging countries including India have become favored destination for medical device companies to leverage the growth opportunities. However, the Indian regulatory system is not ready to meet the challenges that may come up with growing medical device business. It needs major amendments to current Drugs and Cosmetic Act 1940, to include medical device as a separate entity. Like in developed world, the challenges could be addressed by defining medical devices, risk based classification of devices, guidelines for device safety surveillance, and clinical trials for medical devices. Drugs and Cosmetic (Amendment) Bill 2013, which is yet to be released has addressed the concerns to some extent. However, it needs a major revamp to establish effective regulatory framework for medical devices.
Other Latest Articles
- Pharmacotherapy in idiopathic pulmonary fibrosis
- Glaucoma: role of neuroprotective agents
- Medication adherence: the critical step towards better patient outcome
- A Comparative Analysis on Subsidy Policies of China’s Public Housing Programmes: Evidence Based on Micro Surveys in Baoji
- Socially Responsible Investment: A Comparison between the Performance of Sustainable and Traditional Stock Indexes
Last modified: 2014-10-25 16:50:48